Cryptochid
New Member
My first post. The history in Melbourne, Australia of cryptochidism with in vivo Human Pituitary Gonadotrophin....now getting the right treatment
In Australia, from the early 1970's, prepubertal and adolescent boys with a prediction of 'short stature' (recruitment article, Melbourne Herald, November 1971) were treated with pituitary hormones (human pituitary gonadotrophin, hPG) a fertility drug of "protein", taken from cadavers, infused into short statured boys, causing hyperstimulation (cryptorchidism) to the testes, and then treated with synthetic androgens to treat the damage.
One cannot under estimate the effects of exposure to "other persons" brain protein being infused, damaging the 8th Cranial nerve requiring treatment for Hyperkinetic Syndrome, hyperstimulated with pituitary hormones.
Animal studies in the mid 1960's showed young male calves exposed to hPG made cryptorchid, and experiments on the boys had the same effects in the early 1970's.
Some side effects to the Program including Traumatic Brain Injury with vestibular dysfunction of the cranial nerve, Post Adreanal Insifficiency leading to hospitalization, Attempted Suicides and Ideation. Salt wasting with volume depletion is the hallmark of this syndrome. Clinically, patients manifesting CSW are dehydrated, lose weight, have orthostatic hypotension, and demonstrate a negative fluid balance.
The oxandrolone was used in the belief to accelerate linear height, but oxandrolone (testosterone) is used for hypogonadism (damaged testes)
Synthetic steroids acts as a hormone blocker. Oxandrolone is no longer used as a growth promotant, due to side effects.
The hidden agenda, and the short statured boys werent advised was the secret development of the male birth control pill in collaboration with the World Health Organization (WHO) (refer to website)
"Three decades on, the male pill has still not arrived. The most recent breakthrough came earlier this month (October 2003), with the announcement by Australian scientists of a treatment involving an implant under the skin meaning men could not forget to take it of hormones that switch off sperm production. Its said to be 100 per cent effective and free from unpleasant side effects."
Oxandrolone (an anabolic steroid) was used after the radioimmunoassay, "in vivo" study, of FSH/LH causing the hyperstimulation of the gonads, resulting in one form of cryptorchidism (ectopic testes). FSH levels rose 9 fold after hyperstimuation (precosious puberty - neuroendocrine with hPG and doubling testosterone levels). Hyperstimulation causing castration! Bilateral orchidopexy was required to relocate the hyperstimulated testes back into the scotum 6 weeks after exposure, invivo of hPG.
The infusion of hPG hyperstimulated the testes as indicated with an elevated FSH level and testosterone increase from 122 to 250 ng, as a 10 year old.
7.56 The measure of potency was particularly important for hPG recipients where there was a risk of multiple pregnancies or hyperstimulation of the ovaries, a potentially fatal condition, if dosage was incorrect. CSL stated in its submission to the Committee that every single batch of pituitary product was assayed for potency. It also developed additional assays requested by HPAC, for example the luteinizing hormone assay, introduced in 1972.[71].
Never disclosed to the Inquiry was the hyperstimulation effect on the boys at Prince Henry's, and the short term and long term effects upon the testes. Cryptorchidism (ectopic testes) was certainly a side effect to the experiement, an experiment never disclosed to the boys.
Hyperpigmentation, Melanoma, Basal Cell Carcinoma, nocturnal enuresis, prostate disease, gynecomastia, IBS, fluid retention, inreased bladder muscle markings, knock knee, vestibular dysfunction, Myoclonic jerks, muscle spazms, Low FSH and Testosterone, Skeletal dysplasia, Liver disease, osteoporosis and growth stunting to name a few side effects, notwithstanding puberty was never completed. Attempting suicide through self harm as a withdrawal effect, and enduring nervous breakdowns were apart of the experience of endocrine disruption with hormones and sex steroids.
9.108 (Allars pg. 620) In 1985 a nurse of some of the treating medical practitioners at Prince Henry"s, forwarded to the Deptartment of Health a list of hPG recipients in response to the third Department letter. One of the treating medical practitioners did not recall this request of the Department in 1985.
"It is also important to acknowledge the participation of numerous patients in the studies described. Without their help, clinical research would not be possible and quite often their misfortune prompted a new study or helped to elucidate a novel concept"
The Pituitary and Testes - Clinical and Experimental Studies 1983
Concerns are raised upon page 460 of The Allars Report where The Subcommittee approved themselves to Hyperstimulate with hPG. Disclosure and side effects of the potential deaths and castration wasnt concented to by the subjects, nor their Parents.
A fertility treatment used in 10 year old boys that had devistating effects. The boys were left with hypogonadrophic hypogonadism, they didn't complete Tanner Stage V Puberty, and have been refused treatment for the last 25 years.
The LH stimulated androgen secretion in males to from .2 to 1.8 (the adult range in a 10 year old). Oxandrolone kicked the testosterone levels to Tanner Stage 111 (14-18 year old) as a 12 year old, with FSH after hPG exposure into the adult range (PP). Tanner Stage V was never achieved. Precosious Puberty as a 10 year old with an adult range (libido) was most concerning.
Premature aging, 30 years on is a major consequence of the refusal of treatment for the condition. It becomes a major concern when the hPG administration has been associated with deaths of CJD - the human equivilant of BSE/Mad Cow Disease, with an incubation period of upto 38 years after the Stimulation Test for GH deficiency.
.......................................................................................................
The problem with many of the compounds that have been used over the years was side effects.
Although it is quite simple to make a man infertile, it has to be achieved with an acceptable level of side effects.
It is known that 2 out of 3 males with childhood cryptorchidism will be infertile. The fertility rate of enduced "ectopic testes" with hPG exposure is unknown.
Various compounds have had different side effects, including acne, weight gain, increased appetite, mood changes, lethargy and longterm impotence. Some of the side effects experienced are similar to those reported by women on the Pill. Unlike womens estrogen to be "replaced" every month, male testosterone levels drop off over the years.
"Many of the chemicals that have been tried do work, but they also have side effects," Robaire says. "You can easily block the production of the male hormone, and then you obviously have a contraceptive, but that is equivalent to a castration, and that is not good."
http://www.theage.com.au/articles/2003/10/26/1067103267041.html?from=storyrhs&oneclick=true
........................................................................................................
Using Batch 25 FSH (combined with LH), and a further release of Batch 25 on 21st April 1972, The in vivo study wasn't "ratified" by the FSH Subcommittee until September 1972; 5 months after it was used as an unapproved fertility agent causing hyperstimulation. Batch 25 was stated by Turner on 23/12/71 to be dispensed but not tested, yet HPAC released a further batch of the same batch in April 1972, and ratified it shortly afterwards.
2.70 In evidence Professor Whitworth stated:
The Human Pituitary Advisory Committee instituted a requirement that any specialist seeking to be approved by them to treat patients with hPG must have access to a laboratory to carry out the assays required. A computerised recording system was developed in the [Health] department which doctors were required to provide information to on the outcome of treatment. Certainly, hyperstimulation remains a side effect of gonadotropin treatment to this present day.
Prior to 1979, (1972-1976), FSH was a combination of FSH and LH. with the importation of FSH and LH from overseas pituitary glands, a gift from the National Pituitary Agency (Bethesda, Maryland)and Dr Anne Stockell Hartree (University of Cambridge, England), used on males, including prepubertal at Prince Henry's Hospital.
No thorough multidisciplinary, long-term follow-up has ever been done with regard to this treatment, the NHMRC Recinded the "follow up application". Many of the Australian Men now report a range of medical problems which they fear may be the result of their treatment with androgens, after hyperstimulation of LH.
There is however evidence about their concerns since the fact that Oxandrolone treatment was discontinued in 1990 and other Growth promotors such as Human Growth Hormone (hGH) has now ceased being manufactured from Pituiarty Glands in 1985.
Hudson of Melbourne University, leading a United Nations' task force hoped to give the world a male birth control pill. The funding was granted by the NHMRC, and 30 years on their has been no gain in achieving the Pill, not help for those subjected to this experiment.
The boys at PHH were treated with oxandrolone (an anabolic steroid) that encouraged growth but prematurely closed the growth plates. Other concerns surround the estrogenic effects with the conversion of testosterone into estrogen, leaving the boys with gynecomastia and prostate disease (BPH) as a teenager.
We hope this group will be able to support you and help with the side effects of this hormone program. The program that was an in-patient ("in vivo") experiment, without consent or "approval".
One recipient told the committee "All who conspired to force this terrible legacy on hPG and hGH [human growth hormone] recipients are now being protected by a government and its officers who would rather see innocent recipients denied justice than admit to the ineptitude and negligence of those involved in producing these treatments and administering this program."
In Australia, from the early 1970's, prepubertal and adolescent boys with a prediction of 'short stature' (recruitment article, Melbourne Herald, November 1971) were treated with pituitary hormones (human pituitary gonadotrophin, hPG) a fertility drug of "protein", taken from cadavers, infused into short statured boys, causing hyperstimulation (cryptorchidism) to the testes, and then treated with synthetic androgens to treat the damage.
One cannot under estimate the effects of exposure to "other persons" brain protein being infused, damaging the 8th Cranial nerve requiring treatment for Hyperkinetic Syndrome, hyperstimulated with pituitary hormones.
Animal studies in the mid 1960's showed young male calves exposed to hPG made cryptorchid, and experiments on the boys had the same effects in the early 1970's.
Some side effects to the Program including Traumatic Brain Injury with vestibular dysfunction of the cranial nerve, Post Adreanal Insifficiency leading to hospitalization, Attempted Suicides and Ideation. Salt wasting with volume depletion is the hallmark of this syndrome. Clinically, patients manifesting CSW are dehydrated, lose weight, have orthostatic hypotension, and demonstrate a negative fluid balance.
The oxandrolone was used in the belief to accelerate linear height, but oxandrolone (testosterone) is used for hypogonadism (damaged testes)
Synthetic steroids acts as a hormone blocker. Oxandrolone is no longer used as a growth promotant, due to side effects.
The hidden agenda, and the short statured boys werent advised was the secret development of the male birth control pill in collaboration with the World Health Organization (WHO) (refer to website)
"Three decades on, the male pill has still not arrived. The most recent breakthrough came earlier this month (October 2003), with the announcement by Australian scientists of a treatment involving an implant under the skin meaning men could not forget to take it of hormones that switch off sperm production. Its said to be 100 per cent effective and free from unpleasant side effects."
Oxandrolone (an anabolic steroid) was used after the radioimmunoassay, "in vivo" study, of FSH/LH causing the hyperstimulation of the gonads, resulting in one form of cryptorchidism (ectopic testes). FSH levels rose 9 fold after hyperstimuation (precosious puberty - neuroendocrine with hPG and doubling testosterone levels). Hyperstimulation causing castration! Bilateral orchidopexy was required to relocate the hyperstimulated testes back into the scotum 6 weeks after exposure, invivo of hPG.
The infusion of hPG hyperstimulated the testes as indicated with an elevated FSH level and testosterone increase from 122 to 250 ng, as a 10 year old.
7.56 The measure of potency was particularly important for hPG recipients where there was a risk of multiple pregnancies or hyperstimulation of the ovaries, a potentially fatal condition, if dosage was incorrect. CSL stated in its submission to the Committee that every single batch of pituitary product was assayed for potency. It also developed additional assays requested by HPAC, for example the luteinizing hormone assay, introduced in 1972.[71].
Never disclosed to the Inquiry was the hyperstimulation effect on the boys at Prince Henry's, and the short term and long term effects upon the testes. Cryptorchidism (ectopic testes) was certainly a side effect to the experiement, an experiment never disclosed to the boys.
Hyperpigmentation, Melanoma, Basal Cell Carcinoma, nocturnal enuresis, prostate disease, gynecomastia, IBS, fluid retention, inreased bladder muscle markings, knock knee, vestibular dysfunction, Myoclonic jerks, muscle spazms, Low FSH and Testosterone, Skeletal dysplasia, Liver disease, osteoporosis and growth stunting to name a few side effects, notwithstanding puberty was never completed. Attempting suicide through self harm as a withdrawal effect, and enduring nervous breakdowns were apart of the experience of endocrine disruption with hormones and sex steroids.
9.108 (Allars pg. 620) In 1985 a nurse of some of the treating medical practitioners at Prince Henry"s, forwarded to the Deptartment of Health a list of hPG recipients in response to the third Department letter. One of the treating medical practitioners did not recall this request of the Department in 1985.
"It is also important to acknowledge the participation of numerous patients in the studies described. Without their help, clinical research would not be possible and quite often their misfortune prompted a new study or helped to elucidate a novel concept"
The Pituitary and Testes - Clinical and Experimental Studies 1983
Concerns are raised upon page 460 of The Allars Report where The Subcommittee approved themselves to Hyperstimulate with hPG. Disclosure and side effects of the potential deaths and castration wasnt concented to by the subjects, nor their Parents.
A fertility treatment used in 10 year old boys that had devistating effects. The boys were left with hypogonadrophic hypogonadism, they didn't complete Tanner Stage V Puberty, and have been refused treatment for the last 25 years.
The LH stimulated androgen secretion in males to from .2 to 1.8 (the adult range in a 10 year old). Oxandrolone kicked the testosterone levels to Tanner Stage 111 (14-18 year old) as a 12 year old, with FSH after hPG exposure into the adult range (PP). Tanner Stage V was never achieved. Precosious Puberty as a 10 year old with an adult range (libido) was most concerning.
Premature aging, 30 years on is a major consequence of the refusal of treatment for the condition. It becomes a major concern when the hPG administration has been associated with deaths of CJD - the human equivilant of BSE/Mad Cow Disease, with an incubation period of upto 38 years after the Stimulation Test for GH deficiency.
.......................................................................................................
The problem with many of the compounds that have been used over the years was side effects.
Although it is quite simple to make a man infertile, it has to be achieved with an acceptable level of side effects.
It is known that 2 out of 3 males with childhood cryptorchidism will be infertile. The fertility rate of enduced "ectopic testes" with hPG exposure is unknown.
Various compounds have had different side effects, including acne, weight gain, increased appetite, mood changes, lethargy and longterm impotence. Some of the side effects experienced are similar to those reported by women on the Pill. Unlike womens estrogen to be "replaced" every month, male testosterone levels drop off over the years.
"Many of the chemicals that have been tried do work, but they also have side effects," Robaire says. "You can easily block the production of the male hormone, and then you obviously have a contraceptive, but that is equivalent to a castration, and that is not good."
http://www.theage.com.au/articles/2003/10/26/1067103267041.html?from=storyrhs&oneclick=true
........................................................................................................
Using Batch 25 FSH (combined with LH), and a further release of Batch 25 on 21st April 1972, The in vivo study wasn't "ratified" by the FSH Subcommittee until September 1972; 5 months after it was used as an unapproved fertility agent causing hyperstimulation. Batch 25 was stated by Turner on 23/12/71 to be dispensed but not tested, yet HPAC released a further batch of the same batch in April 1972, and ratified it shortly afterwards.
2.70 In evidence Professor Whitworth stated:
The Human Pituitary Advisory Committee instituted a requirement that any specialist seeking to be approved by them to treat patients with hPG must have access to a laboratory to carry out the assays required. A computerised recording system was developed in the [Health] department which doctors were required to provide information to on the outcome of treatment. Certainly, hyperstimulation remains a side effect of gonadotropin treatment to this present day.
Prior to 1979, (1972-1976), FSH was a combination of FSH and LH. with the importation of FSH and LH from overseas pituitary glands, a gift from the National Pituitary Agency (Bethesda, Maryland)and Dr Anne Stockell Hartree (University of Cambridge, England), used on males, including prepubertal at Prince Henry's Hospital.
No thorough multidisciplinary, long-term follow-up has ever been done with regard to this treatment, the NHMRC Recinded the "follow up application". Many of the Australian Men now report a range of medical problems which they fear may be the result of their treatment with androgens, after hyperstimulation of LH.
There is however evidence about their concerns since the fact that Oxandrolone treatment was discontinued in 1990 and other Growth promotors such as Human Growth Hormone (hGH) has now ceased being manufactured from Pituiarty Glands in 1985.
Hudson of Melbourne University, leading a United Nations' task force hoped to give the world a male birth control pill. The funding was granted by the NHMRC, and 30 years on their has been no gain in achieving the Pill, not help for those subjected to this experiment.
The boys at PHH were treated with oxandrolone (an anabolic steroid) that encouraged growth but prematurely closed the growth plates. Other concerns surround the estrogenic effects with the conversion of testosterone into estrogen, leaving the boys with gynecomastia and prostate disease (BPH) as a teenager.
We hope this group will be able to support you and help with the side effects of this hormone program. The program that was an in-patient ("in vivo") experiment, without consent or "approval".
One recipient told the committee "All who conspired to force this terrible legacy on hPG and hGH [human growth hormone] recipients are now being protected by a government and its officers who would rather see innocent recipients denied justice than admit to the ineptitude and negligence of those involved in producing these treatments and administering this program."
